Kirsten Castillo bought $23k of OCGN
director at Ocugen, Inc.. 25,000 shares at an average of $0.91, traded Nov 22, 2024, filed Nov 26, 2024.
Score components
- +15RoleDirector
- 0Trade size$23k at market
- +10Relative to holdingsHoldings up 50%
- 0Price contextNo price history yet
- +8Cluster2 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -10.5%, 3m -33.4%, 6m +5.4%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001062993-24-019706, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 22, 2024 | POpen-market purchase Common Stock | +25,000 | $0.91 | $23k | 75,000 | Nov 26, 2024 |
Related signals
Other insiders at Ocugen, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 29Weak | Ocugen, Inc. | Shankar Musunuri Chief Executive Officer | $589k 525,991 shares | -11% | |
| 31Weak | Ocugen, Inc. | Prabhavathi Fernandes director | $9,095 10,000 shares | - |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.